Portfolio company
Curix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Curix develops a microbubble injection platform and focused ultrasound technology for non-invasive drug delivery across the blood-brain barrier for patients with neurological diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Cortirio
Cortirio develops portable brain imaging headsets that use infrared light to diagnose strokes and traumatic brain injuries at the point of care.
Exact Therapeutics
The company develops an ultrasound-mediated platform for delivering targeted therapies to patients with cancer, neurological conditions and infectious diseases.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
